Overt Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Betahistine HCl

Indications/Uses

Reduce symptoms of vertigo, tinnitus & hearing loss associated w/ Meniere's disease.

Click to view Overt detailed prescribing information

Dosage/Direction for Use

Initially 8-16 mg tid. Maintenance: 24-48 mg daily.

Click to view Overt detailed prescribing information

Administration

Should be taken with food.

Contraindications

Hypersensitivity.

Click to view Overt detailed prescribing information

Special Precautions

Pheochromocytoma. Asthma, existing or history of PUD. Porphyria. Pregnancy.

Click to view Overt detailed prescribing information

Use In Pregnancy & Lactation

Click to view Overt detailed prescribing information

Adverse Reactions

GI disturbances, headache, skin rashes & pruritus.

Click to view Overt detailed prescribing information

Drug Interactions

Decreased effects by β₂-agonists. May decrease response of H₁-antagonists.

Click to view Overt detailed prescribing information

Storage

View Overt storage conditions for details to ensure optimal shelf-life.

Description

View Overt description for details of the chemical structure and excipients (inactive components).

Action

View Overt mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antivertigo Drugs

ATC Classification

N07CA01 - betahistine ; Belongs to the class of antivertigo preparations.

Regulatory Classification

Presentation/Packing

Form

Overt tab 16 mg

Packing/Price

100's (P2,506.84/box)

Form

Overt tab 24 mg

Packing/Price

30's

Form

Overt tab 8 mg

Packing/Price

100's (P1,767.92/box)

Overt

betahistine

Manufacturer:

Cathay YSS

Distributor:

Cathay YSS